148 related articles for article (PubMed ID: 36891896)
1. Crosstalk between circRNAs and the PI3K/AKT and/or MEK/ERK signaling pathways in digestive tract malignancy progression.
Wu C; Huang X; Li M; Wang Z; Zhang Y; Tian B
Future Oncol; 2022 Dec; 18(40):4525-4538. PubMed ID: 36891896
[TBL] [Abstract][Full Text] [Related]
2. Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression.
Xue C; Li G; Lu J; Li L
Signal Transduct Target Ther; 2021 Nov; 6(1):400. PubMed ID: 34815385
[TBL] [Abstract][Full Text] [Related]
3. Exploring the dual role of circRNA and PI3K/AKT pathway in tumors of the digestive system.
Li P; Huang D; Gu X
Biomed Pharmacother; 2023 Dec; 168():115694. PubMed ID: 37832407
[TBL] [Abstract][Full Text] [Related]
4. Circular RNAs Involved in the Regulation of the Age-Related Pathways.
Wang S; Xiao F; Li J; Fan X; He Z; Yan T; Yang M; Yang D
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142352
[TBL] [Abstract][Full Text] [Related]
5. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
[No Abstract] [Full Text] [Related]
6. PI3K/Akt-sensitive MEK-independent compensatory circuit of ERK activation in ER-positive PI3K-mutant T47D breast cancer cells.
Aksamitiene E; Kholodenko BN; Kolch W; Hoek JB; Kiyatkin A
Cell Signal; 2010 Sep; 22(9):1369-78. PubMed ID: 20471474
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA_0000326 promotes bladder cancer progression via microRNA-338-3p/ETS Proto-Oncogene 1/phosphoinositide-3 kinase/Akt pathway.
Chen Y; Wang D; Shu T; Sun K; Zhao J; Wang M; Huang Y; Wang P; Zheng H; Cai Z; Yang Z
Bioengineered; 2021 Dec; 12(2):11410-11422. PubMed ID: 34889689
[TBL] [Abstract][Full Text] [Related]
8. Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways.
Yuen HF; Chan KK; Grills C; Murray JT; Platt-Higgins A; Eldin OS; O'Byrne K; Janne P; Fennell DA; Johnston PG; Rudland PS; El-Tanani M
Clin Cancer Res; 2012 Jan; 18(2):380-91. PubMed ID: 22090358
[TBL] [Abstract][Full Text] [Related]
9. PI3K/AKT/mTOR signaling pathway modulation by circular RNAs in breast cancer progression.
Karami Fath M; Akhavan Masouleh R; Afifi N; Loghmani S; Tamimi P; Fazeli A; Mousavian SA; Falsafi MM; Barati G
Pathol Res Pract; 2023 Jan; 241():154279. PubMed ID: 36584499
[TBL] [Abstract][Full Text] [Related]
10. Circular RNAs: Regulators of endothelial cell dysfunction in atherosclerosis.
Jin T; Wang H; Liu Y; Wang H
J Mol Med (Berl); 2024 Mar; 102(3):313-335. PubMed ID: 38265445
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
[TBL] [Abstract][Full Text] [Related]
12. Microarray Expression Profile and Functional Analysis of Circular RNAs in Osteosarcoma.
Liu W; Zhang J; Zou C; Xie X; Wang Y; Wang B; Zhao Z; Tu J; Wang X; Li H; Shen J; Yin J
Cell Physiol Biochem; 2017; 43(3):969-985. PubMed ID: 28957794
[TBL] [Abstract][Full Text] [Related]
13. Fak/Src signaling in human intestinal epithelial cell survival and anoikis: differentiation state-specific uncoupling with the PI3-K/Akt-1 and MEK/Erk pathways.
Bouchard V; Demers MJ; Thibodeau S; Laquerre V; Fujita N; Tsuruo T; Beaulieu JF; Gauthier R; Vézina A; Villeneuve L; Vachon PH
J Cell Physiol; 2007 Sep; 212(3):717-28. PubMed ID: 17443665
[TBL] [Abstract][Full Text] [Related]
14. CircIL4R activates the PI3K/AKT signaling pathway via the miR-761/TRIM29/PHLPP1 axis and promotes proliferation and metastasis in colorectal cancer.
Jiang T; Wang H; Liu L; Song H; Zhang Y; Wang J; Liu L; Xu T; Fan R; Xu Y; Wang S; Shi L; Zheng L; Wang R; Song J
Mol Cancer; 2021 Dec; 20(1):167. PubMed ID: 34922544
[TBL] [Abstract][Full Text] [Related]
15. EGF/EGFR Promotes Salivary Adenoid Cystic Carcinoma Cell Malignant Neural Invasion
Ren Y; Hong Y; He W; Liu Y; Chen W; Wen S; Sun M
Curr Cancer Drug Targets; 2022; 22(7):603-616. PubMed ID: 35410600
[TBL] [Abstract][Full Text] [Related]
16. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
17. PIK3CA mutations-mediated downregulation of circLHFPL2 inhibits colorectal cancer progression via upregulating PTEN.
Chong X; Chen J; Zheng N; Zhou Z; Hai Y; Chen S; Zhang Y; Yu Q; Yu S; Chen Z; Bao W; Quan M; Chen ZS; Zhan Y; Gao Y
Mol Cancer; 2022 May; 21(1):118. PubMed ID: 35619132
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA circ_0006089 promotes the progression of gastric cancer by regulating the miR-143-3p/PTBP3 axis and PI3K/AKT signaling pathway.
Lin GR; Chen WR; Zheng PH; Chen WS; Cai GY
J Dig Dis; 2022 Jul; 23(7):376-387. PubMed ID: 35844201
[TBL] [Abstract][Full Text] [Related]
19. Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells.
Kwon DS; Kwon CH; Kim JH; Woo JS; Jung JS; Kim YK
Eur J Cell Biol; 2006 Nov; 85(11):1189-99. PubMed ID: 16860436
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of either phosphatidylinositol 3-kinase/Akt or the mitogen/extracellular-regulated kinase, MEK/ERK, signaling pathways suppress growth of breast cancer cell lines, but MEK/ERK signaling is critical for cell survival.
Ripple MO; Kalmadi S; Eastman A
Breast Cancer Res Treat; 2005 Sep; 93(2):177-88. PubMed ID: 16187238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
